Clinical Trial Update: Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update on pharmacokinetics of a single treatment cycle of AA4500 0.58 mg in men with Peyronie's Disease; study completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peyronie Disease

Drugs mentioned

• AA4500

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Peyronie's Disease | Phase 2 | Status: COMPLETED | Results posted: 2015-05-06